Open House: Drug Discount Contracts for Therapy Allergens for Subcutaneous Immunotherapy, ATC V01AA02

This German tender concerns drug discount contracts for therapy allergens used in subcutaneous immunotherapy, specifically coded under ATC V01AA02. The 'Open House' designation suggests a continuous or recurring procurement process. The tender is managed through the communication portal www.dtvp.de, with a strict deadline for contract conclusion on the first day of each month, ending on the third day of the preceding month. This implies a need for a steady supply of these specific allergens. Subcutaneous immunotherapy (SCIT) is a long-term treatment for allergies, involving the administration of gradually increasing doses of allergens to desensitize the patient. The procurement aims to secure cost-effective supplies of these vital therapeutic agents through discount contracts. Bidders must adhere to the submission deadlines and procedures outlined. This tender is crucial for ensuring the availability of essential allergy treatments for patients under the specified therapeutic regimen.